5 of 51 articles - Show All
  1. TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues", Blood, vol. 109, no. 10, pp. .

    Volume 2007 Pages: 4328-4335
    Zhang Z , Gorman C , Vermi A , Monaco C , Foey A , Owen S , Amjadi P , Vallance A , McClinton C , Marelli-Berg F , Isomaki P , Russell A , Dazzi F , Vyse T , Brennan F , Cope A
  2. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane", The Journal of rheumatology, vol. 26, no. 12, pp. .

    Volume 1999 Pages: 2523-2528
    Youssef P , Roth J , Frosch M , Costello P , Fitzgerald O , Sorg C , Bresnihan B
  3. Anti-keratin antibodies in rheumatoid arthritis", British medical journal, vol. 2, no. 6182, pp. .

    Volume 1979 Pages: 97-99
    Young B , Mallya R , Leslie R , Clark C , Hamblin T
  4. A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis", Arthritis and Rheumatism, vol. 64, no. 6, pp. .

    Volume 2012 Pages: 1730-1739
    Yellin M , Paliienko I , Balanescu A , Ter-Vartanian S , Tseluyko V , Xu L , Tao X , Cardarelli P , Leblanc H , Nichol G , Ancuta C , Chirieac R , Luo A
(No collections found)